Company Profile
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease, a mobile application that provides users access to medical imaging results; and Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Latest News
Prediction: Bitcoin Will Hit $1 Million -- Here's the Timeline
Rio Tinto, Western Australia Sign Agreements for Proposed Sale of Desalination Plant to Yindjibarndi WaterCo
Luxfer (LXFR) Q2 Earnings: What To Expect
SK Group, Nvidia sign $500bn deal for AI infrastructure
Baker Hughes Q2 Adjusted Earnings Rise, Revenue Falls; Shares Up Pre-Bell
| Sector | Healthcare |
| Industry | Health Information Services |
| Website | https://www.promed.com.au |
| Audit Risk | 1 |
| Board Risk | 8 |
| Overall Risk | 8 |
| Market Cap | 16.95B |
| Trailing P/E | 72.43 |
| Forward P/E | 90.19 |
| Dividend Rate | 0.64 |
| Dividend Yield | 0.40% |
| Trailing Annual Div. Rate | 0.62 |
| Trailing Annual Div. Yield | 0.39% |
| Trailing EPS | 2.24 |
| Forward EPS | 1.8 |
| Book Value | 3.72 |
| Price-to-Book | 43.59 |
| Enterprise-to-Revenue | 68.5 |
| Enterprise-to-EBITDA | 92.11 |
| Ex-Dividend Date | 02/26/2026 |
| Earnings Date | 08/18/2026 |
| Earnings Call Date | 08/18/2026 |